APA

Ananworanich J., Gayet-Ageron A., Ruxrungtham K., Chetchotisakd P., Prasithsirikul W., Kiertiburanakul S., Munsakul W., Raksakulkarn P., Tansuphasawadikul S., LeBraz M., Jupimai T., Ubolyam S., Schutz M. & Hirschel B. (20080717). Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. : Antiviral therapy.

Chicago

Ananworanich Jintanat, Gayet-Ageron Angele, Ruxrungtham Kiat, Chetchotisakd Ploenchan, Prasithsirikul Wisit, Kiertiburanakul Sasisopin, Munsakul Warangkana, Raksakulkarn Phitsonu, Tansuphasawadikul Somboon, LeBraz Michelle, Jupimai Thidarat, Ubolyam Sasiwimol, Schutz Malte and Hirschel Bernard. 20080717. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. : Antiviral therapy.

Harvard

Ananworanich J., Gayet-Ageron A., Ruxrungtham K., Chetchotisakd P., Prasithsirikul W., Kiertiburanakul S., Munsakul W., Raksakulkarn P., Tansuphasawadikul S., LeBraz M., Jupimai T., Ubolyam S., Schutz M. and Hirschel B. (20080717). Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. : Antiviral therapy.

MLA

Ananworanich Jintanat, Gayet-Ageron Angele, Ruxrungtham Kiat, Chetchotisakd Ploenchan, Prasithsirikul Wisit, Kiertiburanakul Sasisopin, Munsakul Warangkana, Raksakulkarn Phitsonu, Tansuphasawadikul Somboon, LeBraz Michelle, Jupimai Thidarat, Ubolyam Sasiwimol, Schutz Malte and Hirschel Bernard. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. : Antiviral therapy. 20080717.